Novozymes A/S
XBER:NZM2
Novozymes A/S
XBER:NZM2
Price:
54.62
EUR
Market Closed
Market Cap:
€15.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
XBER:NZM2
|
DK |
|
Jardine Matheson Holdings Ltd
LSE:JARB
|
HK |
|
F
|
Federal Home Loan Mortgage Corp
LSE:0IKZ
|
US |
|
Mind Medicine (MindMed) Inc
F:MMQ
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FMEN
|
DE |
|
C
|
CDW Corp
F:CDW
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Not Available
NZM2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
